Literature DB >> 18929897

Effect of aciclovir on HIV-1 acquisition in HSV-2-positive patients.

C P Hudson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18929897     DOI： 10.1016/S0140-6736(08)61543-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

1.  A new class of dual-targeted antivirals: monophosphorylated acyclovir prodrug derivatives suppress both human immunodeficiency virus type 1 and herpes simplex virus type 2.

Authors:  Christophe Vanpouille; Andrea Lisco; Marco Derudas; Elisa Saba; Jean-Charles Grivel; Beda Brichacek; Francesca Scrimieri; Raymond Schinazi; Dominique Schols; Christopher McGuigan; Jan Balzarini; Leonid Margolis
Journal:  J Infect Dis       Date:  2010-02-15       Impact factor: 5.226

2.  A missed point in deciphering the viral synergy between herpes simplex virus and HIV.

Authors:  Andrea Lisco; Christophe Vanpouille; Leonid Margolis
Journal:  Lancet Infect Dis       Date:  2009-09       Impact factor: 25.071
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.